Business Description
Daito Pharmaceutical Co Ltd
ISIN : JP3486150000
Description
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.31 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 1.91 | |||||
| Interest Coverage | 66.58 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.56 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.7 | |||||
| 3-Year EBITDA Growth Rate | -5.7 | |||||
| 3-Year EPS without NRI Growth Rate | -12.6 | |||||
| 3-Year FCF Growth Rate | 3.5 | |||||
| 3-Year Book Growth Rate | 7.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.38 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.04 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.48 | |||||
| 9-Day RSI | 37.24 | |||||
| 14-Day RSI | 38.42 | |||||
| 6-1 Month Momentum % | -5.16 | |||||
| 12-1 Month Momentum % | 11.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.24 | |||||
| Quick Ratio | 1.11 | |||||
| Cash Ratio | 0.15 | |||||
| Days Inventory | 192.08 | |||||
| Days Sales Outstanding | 88.02 | |||||
| Days Payable | 54.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.12 | |||||
| Dividend Payout Ratio | 0.35 | |||||
| 3-Year Dividend Growth Rate | 12.8 | |||||
| Forward Dividend Yield % | 3.36 | |||||
| 5-Year Yield-on-Cost % | 5.57 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | -1.97 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.29 | |||||
| Operating Margin % | 7.73 | |||||
| Net Margin % | 6.82 | |||||
| FCF Margin % | -2.31 | |||||
| ROE % | 6.27 | |||||
| ROA % | 4.34 | |||||
| ROIC % | 3.85 | |||||
| ROC (Joel Greenblatt) % | 8.9 | |||||
| ROCE % | 7.98 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.06 | |||||
| Forward PE Ratio | 11.73 | |||||
| PE Ratio without NRI | 12.07 | |||||
| Shiller PE Ratio | 8.39 | |||||
| PS Ratio | 0.69 | |||||
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| Price-to-Operating-Cash-Flow | 6.31 | |||||
| EV-to-EBIT | 8.26 | |||||
| EV-to-EBITDA | 8.26 | |||||
| EV-to-Revenue | 0.8 | |||||
| EV-to-FCF | -34.83 | |||||
| Price-to-Projected-FCF | 0.73 | |||||
| Price-to-Median-PS-Value | 0.77 | |||||
| Price-to-Graham-Number | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 2.01 | |||||
| Earnings Yield (Greenblatt) % | 12.1 | |||||
| FCF Yield % | -3.43 | |||||
| Forward Rate of Return (Yacktman) % | -0.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daito Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 47,395 | ||
| EPS (TTM) (円) | 207.02 | ||
| Beta | 0.35 | ||
| Volatility % | 22.6 | ||
| 14-Day RSI | 38.42 | ||
| 14-Day ATR (円) | 40.897989 | ||
| 20-Day SMA (円) | 2109.2 | ||
| 12-1 Month Momentum % | 11.62 | ||
| 52-Week Range (円) | 1803 - 2573 | ||
| Shares Outstanding (Mil) | 15.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Daito Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Daito Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Daito Pharmaceutical Co Ltd Frequently Asked Questions
What is Daito Pharmaceutical Co Ltd(TSE:4577)'s stock price today?
The current price of TSE:4577 is 円2078.00. The 52 week high of TSE:4577 is 円2573.00 and 52 week low is 円1803.00.
When is next earnings date of Daito Pharmaceutical Co Ltd(TSE:4577)?
The next earnings date of Daito Pharmaceutical Co Ltd(TSE:4577) is .
Does Daito Pharmaceutical Co Ltd(TSE:4577) pay dividends? If so, how much?
The Dividend Yield %  of Daito Pharmaceutical Co Ltd(TSE:4577) is 3.12% (As of Today), Highest Dividend Payout Ratio of Daito Pharmaceutical Co Ltd(TSE:4577) was 0.35. The lowest was 0.13. And the median was 0.14. The  Forward Dividend Yield % of Daito Pharmaceutical Co Ltd(TSE:4577) is 3.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers